FDA Issues Recall of Syringes Used by Diabetics

Today the FDA issued a recall of Insulin syringes referred to as ReliOn. These are single-use, disposable, hypodermic syringes used by patients with insulin dependent diabetes. The syringe is mislabeled and may result in the patient overdosing by as much as 2.5 times the intended dose. This can lead to serious health consequences, including death. The syringes were sold by Wal-Mart and Sam’s Club pharmacies. The recall only applies to lot number 813900. The product was distributed from August through October 8th of this year. You should check your syringe packaging carefully and do not use this product and return to the pharmacy for a replacement. For more information regarding this recall, see here.